Ralph H. Thurman's Insider Trades & SAST Disclosures
Ralph H. Thurman's most recent trade in Outlook Therapeutics Inc was a trade of 89,549 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Oct. 1, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ralph H. Thurman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Outlook Therapeutics Inc | Ralph H. Thurman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 89,549 | 89,549 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Ralph H. Thurman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 56,636 | 56,636 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Ralph H. Thurman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 94,441 | 94,441 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Ralph H. Thurman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 41,065 | 41,065 | - | - | Stock Option (Right to Buy) | |
| Tff Pharmaceuticals Inc | Ralph H. Thurman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2022 | 40,255 | 84,670 | - | - | Stock Options (Right to Buy) | |
| Tff Pharmaceuticals Inc | Ralph H. Thurman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 29 Sep 2022 | 40,255 | 40,255 (0%) | 0% | 2.5 | 100,638 | Common Stock |
| Tff Pharmaceuticals Inc | Ralph H. Thurman | Director | Sale of securities on an exchange or to another person at price $ 4.29 per share. | 29 Sep 2022 | 40,255 | 0 (0%) | 0% | 4.3 | 172,694 | Common Stock |
| Outlook Therapeutics Inc | Ralph H. Thurman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2022 | 81,878 | 81,878 | - | - | Stock Option (Right to Buy) | |
| Tff Pharmaceuticals Inc | Ralph H. Thurman | Director | Purchase of securities on an exchange or from another person at price $ 9.40 per share. | 18 May 2021 | 1,050 | 1,050 (0%) | 0% | 9.4 | 9,870 | Common Stock |
| Outlook Therapeutics Inc | Ralph H. Thurman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 20,873 | 20,873 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges